{"id":32199,"date":"2025-07-30T08:39:37","date_gmt":"2025-07-30T08:39:37","guid":{"rendered":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/"},"modified":"2025-07-30T08:39:37","modified_gmt":"2025-07-30T08:39:37","slug":"ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/","title":{"rendered":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae)."},"content":{"rendered":"<p>JESUS SALVADOR JIMENEZ LOPEZ &#8211; ENSAYO CLINICO COMERCIAL &#8211; II &#8211; LINICAL SPAIN, S.L.U.<\/p>","protected":false},"excerpt":{"rendered":"<p>JESUS SALVADOR JIMENEZ LOPEZ &#8211; ENSAYO CLINICO COMERCIAL &#8211; II &#8211; LINICAL SPAIN, S.L.U.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2290],"tags":[],"class_list":["post-32199","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-c-16-ensayos-clinicos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima\" \/>\n<meta property=\"og:description\" content=\"JESUS SALVADOR JIMENEZ LOPEZ &#8211; ENSAYO CLINICO COMERCIAL &#8211; II &#8211; LINICAL SPAIN, S.L.U.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T08:39:37+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae).\",\"datePublished\":\"2025-07-30T08:39:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/\"},\"wordCount\":61,\"commentCount\":0,\"articleSection\":[\"Ensayos Cl\u00ednicos\",\"Ensayos Cl\u00ednicos - C-16\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/\",\"name\":\"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-07-30T08:39:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae).\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/","og_locale":"en_GB","og_type":"article","og_title":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima","og_description":"JESUS SALVADOR JIMENEZ LOPEZ &#8211; ENSAYO CLINICO COMERCIAL &#8211; II &#8211; LINICAL SPAIN, S.L.U.","og_url":"https:\/\/ibima.eu\/en\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/","og_site_name":"Ibima","article_published_time":"2025-07-30T08:39:37+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae).","datePublished":"2025-07-30T08:39:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/"},"wordCount":61,"commentCount":0,"articleSection":["Ensayos Cl\u00ednicos","Ensayos Cl\u00ednicos - C-16"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/","url":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/","name":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae). - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-07-30T08:39:37+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/ensayo-clinico-de-fase-2-multicentrico-abierto-aleatorizado-para-evaluar-la-inhibicion-de-la-ovulacion-de-tres-dosificaciones-de-levonorgestrel-lng-en-un-sistema-de-liberacion-vaginal-slv-que\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Ensayo cl\u00ednico de fase 2, multic\u00e9ntrico, abierto, aleatorizado, para evaluar la inhibici\u00f3n de la ovulaci\u00f3n de tres dosificaciones de levonorgestrel (LNG) en un sistema de liberaci\u00f3n vaginal (SLV), que se libera durante 28 d\u00edas de manera continua, frente a desogestrel (Cerazet\u00ae)."}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=32199"}],"version-history":[{"count":3,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32199\/revisions"}],"predecessor-version":[{"id":55210,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32199\/revisions\/55210"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=32199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=32199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=32199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}